Stokes Family Office, LLC Bristol Myers Squibb CO Transaction History

Stokes Family Office, LLC

$834 Million
Q2 2024

A detailed history of Stokes Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stokes Family Office, LLC holds 40,869 shares of BMY stock, worth $2.17 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

40,869

Previous 41,225 0.86%

Holding current value

$2.17 Million

Previous $2.24 Million 24.07%

% of portfolio

0.2%

Previous 0.28%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	SELL	$40.25 - $52.99 $14,329 - $18,864	-356 Reduced 0.86%	40,869 $1.7 Million
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $37,472 - $42,486	781 Added 1.93%	41,225 $2.24 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $67,435 - $80,469	-1,391 Reduced 3.32%	40,444 $2.08 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $14,356 - $16,053	248 Added 0.6%	41,835 $2.43 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $18,475 - $20,514	290 Added 0.7%	41,587 $2.66 Million
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $21,092 - $23,924	-321 Reduced 0.77%	41,297 $2.86 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $51,291 - $60,736	749 Added 1.83%	41,618 $2.99 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $85 - $50,560	658 Added 1.64%	40,869 $2.91 Million
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $50,035 - $55,106	689 Added 1.74%	40,211 $3.1 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $10,943 - $13,122	178 Added 0.45%	39,522 $2.89 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $47,248 - $55,080	-881 Reduced 2.19%	39,344 $2.45 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $32,602 - $38,189	-551 Reduced 1.35%	40,225 $2.38 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $47,113 - $51,306	761 Added 1.9%	40,776 $2.73 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $67,766 - $76,217	1,142 Added 2.94%	40,015 $2.53 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $22,865 - $25,910	396 Added 1.03%	38,873 $2.41 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $47,954 - $53,139	835 Added 2.22%	38,477 $2.32 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $40,950 - $47,875	747 Added 2.02%	37,642 $2.21 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $5,104 - $7,417	110 Added 0.3%	36,895 $2.06 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $1.81 Million - $2.36 Million	36,785 New	36,785 $2.36 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.

Account

Stokes Family Office, LLC Bristol Myers Squibb CO Transaction History